Cardio Diagnostics Holdings Stock Market Value
| CDIO Stock | USD 1.78 0.06 3.26% |
| Symbol | Cardio |
Will Biotechnology sector continue expanding? Could Cardio diversify its offerings? Factors like these will boost the valuation of Cardio Diagnostics. Projected growth potential of Cardio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cardio Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.91) | Revenue Per Share | Quarterly Revenue Growth (0.57) | Return On Assets | Return On Equity |
Cardio Diagnostics's market price often diverges from its book value, the accounting figure shown on Cardio's balance sheet. Smart investors calculate Cardio Diagnostics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Cardio Diagnostics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cardio Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardio Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cardio Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cardio Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cardio Diagnostics.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Cardio Diagnostics on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Cardio Diagnostics Holdings or generate 0.0% return on investment in Cardio Diagnostics over 90 days. Cardio Diagnostics is related to or competes with Addex Therapeutics, Brainstorm Cell, Neurosense Therapeutics, Matinas BioPharma, Creative Medical, Adial Pharmaceuticals, and Alaunos Therapeutics. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of ca... More
Cardio Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cardio Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cardio Diagnostics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 38.04 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 8.44 |
Cardio Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardio Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cardio Diagnostics' standard deviation. In reality, there are many statistical measures that can use Cardio Diagnostics historical prices to predict the future Cardio Diagnostics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.16) | |||
| Total Risk Alpha | (1.60) | |||
| Treynor Ratio | (0.34) |
Cardio Diagnostics January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.33) | |||
| Mean Deviation | 5.09 | |||
| Coefficient Of Variation | (739.70) | |||
| Standard Deviation | 7.1 | |||
| Variance | 50.46 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.16) | |||
| Total Risk Alpha | (1.60) | |||
| Treynor Ratio | (0.34) | |||
| Maximum Drawdown | 38.04 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 8.44 | |||
| Skewness | 0.8139 | |||
| Kurtosis | 2.12 |
Cardio Diagnostics Backtested Returns
Cardio Diagnostics secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of risk over the last 3 months. Cardio Diagnostics Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cardio Diagnostics' Risk Adjusted Performance of (0.09), standard deviation of 7.1, and Mean Deviation of 5.09 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.85, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardio Diagnostics will likely underperform. At this point, Cardio Diagnostics has a negative expected return of -1.1%. Please make sure to confirm Cardio Diagnostics' potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Cardio Diagnostics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.28 |
Poor predictability
Cardio Diagnostics Holdings has poor predictability. Overlapping area represents the amount of predictability between Cardio Diagnostics time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cardio Diagnostics price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Cardio Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.39 |
Pair Trading with Cardio Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardio Stock
Moving against Cardio Stock
| 0.73 | CING | Cingulate | PairCorr |
| 0.48 | OABI | OmniAb Inc | PairCorr |
| 0.44 | PPERY | Bank Mandiri Persero Earnings Call This Week | PairCorr |
| 0.39 | PEPG | PepGen | PairCorr |
| 0.39 | ARMP | Armata Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Cardio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardio Diagnostics Holdings to buy it.
The correlation of Cardio Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cardio Diagnostics Correlation, Cardio Diagnostics Volatility and Cardio Diagnostics Alpha and Beta module to complement your research on Cardio Diagnostics. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Cardio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.